Galsulfase for Enzyme Replacement Therapy AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Procurement object * Goods to be procured: Galsulfase (active substance) for enzyme replacement therapy. * Technical requirements: The medicine must comply with the public procurement underlying documents and the bid. The offered medicine must have a marketing authorization from the State Agency of Medicines or the European Commission. * Location: Viljandi Hospital Tervikum building (C. R. Jakobsoni 2a, Viljandi). # Contract terms * Duration: 12 months from the entry into force of the contract…

 
To see full summary, please log in or register.

t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

308483_ESPD_v2.0_laiendatud.xml

308483_hankepass_taiendavate_selgitustega.pdf

308483_hindamiskriteeriumid.pdf

308483_vastavustingimused.pdf

308483.zip

Lepingu lisa 1 Juhis kauba tarneks.pdf

Lisa 1 Tehniline kirjeldus.xls

Lisa 2 Raamlepingu kavand.doc

Pakkumuse esildis.xls

Pakkumuse esitamise ettepanek.doc

Ready to get started?

Subscribe and enjoy all the benefits every day!